Literature DB >> 9159737

6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study.

T Hanihara1, K Inoue, C Kawanishi, N Sugiyama, T Miyakawa, H Onishi, Y Yamada, H Osaka, K Kosaka, K Iwabuchi, M Owada.   

Abstract

We report the case of a 44-year-old woman with a partial 6-pyruvoyl tetrahydropterin synthase (6-PTS) deficiency, whose predominant clinical symptom was generalized dystonia with marked diurnal fluctuation. Dystonia was present in the eyelids, oromandibular region, trunk, and extremities (Meige syndrome plus double hemiplegia-like dystonia). A marked and sustained positive response to levodopa was observed. A molecular genetic study revealed a homozygous mutation (I114V) in the 6-PTS gene. This study indicates that genetic abnormality in the 6-PTS gene may be a hereditary dystonia disorder. We speculate that our patient has residual 6-PTS activity in the central nervous system, such as in the liver, and we suggest that residual, but insufficient production of tetrahydrobiopterin may play an important role in causing diurnal fluctuation of symptoms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9159737     DOI: 10.1002/mds.870120321

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

2.  Variability of presynaptic nigrostriatal dopaminergic function and clinical heterogeneity in a dopa-responsive dystonia family with GCH-1 gene mutation.

Authors:  Juei-Jueng Lin; Chin-Song Lu; Chon-Haw Tsai
Journal:  J Neurol       Date:  2017-12-30       Impact factor: 4.849

Review 3.  Dopa-responsive dystonia--clinical and genetic heterogeneity.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

Review 4.  Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin.

Authors:  T Nagatsu; H Ichinose
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

Review 5.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

Review 6.  Animal models for dystonia.

Authors:  Bethany K Wilson; Ellen J Hess
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

7.  Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia.

Authors:  Kenta Sato; Chiho Sumi-Ichinose; Ryuji Kaji; Kazuhisa Ikemoto; Takahide Nomura; Ikuko Nagatsu; Hiroshi Ichinose; Masayuki Ito; Wataru Sako; Shinji Nagahiro; Ann M Graybiel; Satoshi Goto
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-19       Impact factor: 11.205

8.  SPG11 Mutations Associated With a Complex Phenotype Resembling Dopa-Responsive Dystonia.

Authors:  Subhashie Wijemanne; Joshua M Shulman; Joohi Jimenez-Shahed; Daniel Curry; Joseph Jankovic
Journal:  Mov Disord Clin Pract       Date:  2015-04-28

9.  Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.

Authors:  Jill R Crittenden; Ann M Graybiel
Journal:  Front Neuroanat       Date:  2011-09-07       Impact factor: 3.856

10.  Genetic diagnosis of two dopa-responsive dystonia families by exome sequencing.

Authors:  Zhan-fang Sun; Yu-han Zhang; Ji-feng Guo; Qi-ying Sun; Jun-pu Mei; Han-lin Zhou; Li-ping Guan; Jin-yong Tian; Zheng-mao Hu; Jia-da Li; Kun Xia; Xin-xiang Yan; Bei-sha Tang
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.